Posted by Clinical Lab Products | Apr 23, 2009 | Cancer, Miscellaneous |
Celera Corp announced the presentation of data describing a novel mass spectrometry-based approach to identify and validate circulating protein biomarkers that detect non-small cell lung cancer.
Read MorePosted by Clinical Lab Products | Mar 13, 2009 | Cancer, Miscellaneous |
A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity.
Read MorePosted by Clinical Lab Products | Mar 7, 2008 | Cancer, Lung Cancer, Molecular Diagnostics |
Abbott, Abbott Park, Ill, has inked an agreement with Genentech Inc, F Hoffmann-La Roche Ltd, and OSI Pharmaceuticals Inc to develop a gene test to potentially assess clinical benefits of an oral tablet for treating patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.
Read MorePosted by Clinical Lab Products | Sep 27, 2007 | Cancer, Miscellaneous |
Gene Express Inc, Toledo, Ohio, says its molecular diagnostic test for lung cancer has demonstrated high levels of accuracy in a recent study.
Read MorePosted by Clinical Lab Products | Aug 18, 2006 | Cancer, Miscellaneous |
Researchers say they have developed a test that can predict with near certainty whether the most common form of lung cancer will return after surgery.
Read More